Crescent Biopharma CBIO SEC Filings

NASDAQ CBIO
$13.92 +0.27 (+1.98%)
At close: Nov 10, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Crescent Biopharma, Inc. (CBIO) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
1SCHEDULE 13GBeneficial Ownership Report0002012383-26-003736Oct 27, 2026 9:25 PM
28-KCurrent Report0001628280-26-066006Oct 15, 2026 12:26 AM
34Insider Transaction0001628280-26-062709Sep 18, 2026 8:03 PM
44Insider Transaction0001628280-26-062707Sep 18, 2026 8:03 PM
54Insider Transaction0001628280-26-062706Sep 18, 2026 8:02 PM
64Insider Transaction0001628280-26-062705Sep 18, 2026 8:02 PM
74Insider Transaction0001628280-26-062703Sep 18, 2026 8:02 PM
84Insider Transaction0001628280-26-062701Sep 18, 2026 8:02 PM
94Insider Transaction0001628280-26-062700Sep 18, 2026 8:01 PM
10S-8Prospectus0001628280-26-062634Sep 18, 2026 4:00 PM
11144Insider Transaction0001628280-26-062529Sep 17, 2026 8:33 PM
12144Insider Transaction0001628280-26-062526Sep 17, 2026 8:32 PM
13144Insider Transaction0001628280-26-062213Sep 16, 2026 3:09 PM
14144Insider Transaction0001628280-26-062211Sep 16, 2026 3:09 PM
15SCHEDULE 13GBeneficial Ownership Report0001172661-26-003420Aug 14, 2026 10:01 AM
16EFFECTOthers9999999995-26-002504Jul 31, 2026 4:15 AM
17POS AMOthers0001628280-26-050885Jul 30, 2026 1:36 PM
18424B3Prospectus0001628280-26-050881Jul 30, 2026 1:34 PM
1910-QQuarterly & Annual Report0001628280-26-050869Jul 30, 2026 1:25 PM
208-KCurrent Report0001628280-26-050805Jul 30, 2026 11:36 AM
21SCHEDULE 13DBeneficial Ownership Report0001104659-26-085114Jul 20, 2026 9:30 PM
224Insider Transaction0001104659-26-085113Jul 20, 2026 9:30 PM
238-KCurrent Report0001628280-26-048347Jul 15, 2026 8:58 PM
24424B5Prospectus0001628280-26-048344Jul 15, 2026 8:56 PM
258-KCurrent Report0001628280-26-048151Jul 14, 2026 8:05 PM
26424B5Prospectus0001628280-26-048144Jul 14, 2026 8:01 PM
27EFFECTOthers9999999995-26-002258Jul 10, 2026 4:15 AM
28S-3Prospectus0001628280-26-046544Jul 1, 2026 8:16 PM
294Insider Transaction0001628280-26-044893Jun 23, 2026 8:04 PM
304Insider Transaction0001628280-26-044892Jun 23, 2026 8:04 PM
314Insider Transaction0001628280-26-044890Jun 23, 2026 8:03 PM
324Insider Transaction0001628280-26-044887Jun 23, 2026 8:03 PM
334Insider Transaction0001628280-26-044886Jun 23, 2026 8:02 PM
344Insider Transaction0001628280-26-044885Jun 23, 2026 8:02 PM
354Insider Transaction0001628280-26-044884Jun 23, 2026 8:01 PM
36424B3Prospectus0001628280-26-044718Jun 22, 2026 9:06 PM
3710-QQuarterly & Annual Report0001628280-26-044713Jun 22, 2026 9:03 PM
384Insider Transaction0001628280-26-040583Jun 3, 2026 11:48 PM
394Insider Transaction0001628280-26-040582Jun 3, 2026 11:48 PM
404Insider Transaction0001628280-26-040580Jun 3, 2026 11:47 PM
414Insider Transaction0001628280-26-040577Jun 3, 2026 11:47 PM
424Insider Transaction0001628280-26-040575Jun 3, 2026 11:46 PM
438-KCurrent Report0001628280-26-040051Jun 3, 2026 1:02 PM
44SCHEDULE 13GBeneficial Ownership Report0001214659-26-006496May 15, 2026 8:15 PM
45SCHEDULE 13GBeneficial Ownership Report0001193125-26-225181May 15, 2026 10:31 AM
46424B3Prospectus0001628280-26-028415Apr 29, 2026 8:28 PM
478-KCurrent Report0001628280-26-028386Apr 29, 2026 8:15 PM
4810-QQuarterly & Annual Report0001628280-26-028362Apr 29, 2026 8:06 PM
49DEFA14AOthers0001628280-26-026291Apr 21, 2026 8:18 PM
50DEFA14AOthers0001628280-26-026285Apr 21, 2026 8:16 PM
...

Crescent Biopharma, Inc. SEC Filings API

Pull Crescent Biopharma, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=CBIO&formtype=10-K,10-Q&api_key=YOUR_API_KEY